Association of schizophrenia in African Americans to polymorphism in synapsin III gene

Psychiatric Genetics

Volumn 15, Issue 2, 2005, Pages 127-132

  Lachman, Herbert M ^a   Stopkova, Pavla ^b   Rafael, Maryam Aghalar ^a   Saito, Takuya ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

22q12 q13; Bipolar disorder; Chromosome 22; Mitogen activated protein kinase; S470N; Synaptic vesicle

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SYNAPSIN; SYNAPSIN 3; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CODON; COHORT ANALYSIS; CONTROLLED STUDY; CZECH REPUBLIC; DNA POLYMORPHISM; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SAMPLE SIZE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; UNITED STATES;

AFRICAN AMERICANS; AMINO ACID SUBSTITUTION; CODON; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SYNAPSINS;

EID: 20444364499     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200506000-00009     Document Type: Article

References (41)

1. Bassett AS, Chow EWC (1999). 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 46:882-891.
2. Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M, et al. (1994). Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 54:72-79.
3. Cremona O, De Camilli P (2001). Phosphoinositides in membrane traffic at the synapse. J Cell Sci 114(Pt 6):1041-1052.
4. De Camilli P, Cameron R, Greengard P (1983). Synapsin I (protein I), a nerve terminal-specific phosphoprotein. I. Its general distribution in synapses of the central and peripheral nervous system demonstrated by immunfluorescence in frozen and plastic sections. J Cell Biol 96:1355-1373.
5. Edenberg HJ, Foroud T, Connealy PM, Sorbel JJ, Carr K, Crose C, et al. (1997). Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet (Neuropsych Genet) 74:238-246.
6. Endicott J, Spitzer RL (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837-844.
7. Feng J, Chi P, Blanpied TA, Xu Y, Magarinos AM, Ferreira A, et al. (2002). Regulation of neurotransmitter release by synapsin III. J Neurosci 22: 4372-4380.
8. Ferreira A, Kao H-T, Feng J, Rapoport M, Greengard P (2000). Synapsin III: developmental expression, subcellular localization, and role in axon formation. J Neurosci 20:3736-3744.
9. Hosaka M, Hammer RE, Südhof TC (1999). A phospho-switch controls the dynamic association of synapsins with synaptic vesicles. Neuron 24:377-387.
10. Imai K, Harada S, Kawanishi Y, Tachikawa Okubo T, Suzuki T (2001). Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia. Neuropsychobiology 43:237-241.
11. Johnson EM, Ueda T, Maeno H, Greengard P (1972). Adenosine 3′5-monophosphate-dependent phosphorylation of a specific protein in synaptic membrane fractions from rat cerebrum. J Biol Chem 247:5650-5652.
12. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, et al. (1995). Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci 92:7612-7616.
13. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, et al. (1998). NIMH genetics initiative millenium schizophrenia consortium: linkage analysis of African-American pedigrees. Am J Med Genet 81:282-289.
14. Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA, et al. (2001). A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci (USA) 98:585-590.
15. Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, et al. (1997). Linkage studies support a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome. Am J Med Genet (Neuropsych Genet) 74:121-128.
16. Lewis CM, Levinson DF, Wise LH, DeLisi LA, Straub RE, Hovatta I, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II. Schizophrenia. Am J Hum Genet 73:34-48.
17. McGuffin P, Tandon K, Corsico A (2003). Linkage and association studies of schizophrenia. Curr Psychiatry Rep 5:121-127.
18. Mimics K, Middleton FA, Morquez A, Lewis DA, Levitt P (2000). Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28(1):53-67.
19. Moghaddam B (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron 40:881-884.
20. Moises HW, Yang L, Li T, Havsteen B, Fimmers R, Baur MP, et al. (1995). Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22. Am J Med Genet 60:465-467.
21. Ohmori O, Shinkai T, Hori H, Kojima H, Nakamura J (2000). Synapsin III gene polymorphisms and schizophrenia. Neurosci Lett 279:125-127.
22. Ohtsuki T, Ichiki R, Toru M, Arinami T (2000). Mutation analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia. Psychiatry Res 94:1-7.
23. Pier GB (2000). Role of cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Proc Natl Acad Sci 97:8822-8828.
24. Pieribone VA, Porton B, Rendon R, Greengard P, Kao H-T (2002). Expression of synapsin III in nerve terminals and neurogenic regions of the adult brain. J Comp Neurol 454:105-114.
25. Porton B, Kao H-T, Greengard P (1999). Characterization of transcripts from the synapsin III gene locus. J Neurochem 73:2266-2271.
26. Porton B, Ferreira A, DeLisi LE, Kao H-T (2004). A rare polymorphism affects a mitogen-activated protein kinase site in synapsin III: possible relationship to schizophrenia. Biol Psychiatry 55:118-125.
27. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G (1994). Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: part 1. Am J Med Genet 54:36-43.
28. Riley B, Mogudi-Carter M, Jenkins T, Williamson R (1996). No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families. Am J Med Genet 67:515-522.
29. Rowntree RK, Harris A (2003). The phenotypic consequences of CFTR mutations. Ann Hum Genet 67(Pt 5):471-485.
30. Saito T, Guan F, Papolos DF, Lau S, Klein M, Fann CSJ, et al. (2001a). Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry 6:387-395.
31. Saito T, Guan F, Papolos D, Namouria N, Lachman HM (2001b). Analysis of SNAP-29, a candidate gene for 22q11 linked psychiatric disorders. Mol Psychiatry 6:193-201.
32. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892.
33. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al. (2003). Association of neuregulin 1 with schizophrenia confirmed in Scottish population. Am J Hum Genet 72:83-87.
34. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, et al. (1998). Dating the origin of the CCR5-Δ32 AIDS-resistance allele by coalescence of haplotypes. Am J Hum Genet 62:1507-1515.
35. Stopkova P, Saito T, Fann CSJ, Papolos DF, Vevera J, Paclt I, et al. (2003). Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet (Neuropsychiatr Genet) 1236:50-58.
36. Stopkova P, Saito T, Papolos DF, Vevera J, Paclt I, Zukov I, et al. (2004). Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry, 55(10):981-988.
37. Takahashi S, Cui YH, Kojima T, Han YH, Zhou RL, Kamioka M, et al. (2003). Family-based association study of markers on chromosome 22 in schizophrenia using African-American, European-American, and Chinese families. Am J Med Genet 1206:11-17.
38. Takei Y, Harada A, Takeda S, Kobayashi K, Terada S, Noda T, et al. (1995). Synapsin I deficiency results in the structural change in the presynaptic terminals in the murine nervous system. J Cell Biol 131:1789-1800.
39. Tsai M-T, Hung C-C, Tsai C-Y, Liu M-Y, Su Y-C, Chen Y-H, et al. (2002). Mutation analysis of synapsin III gene in schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 114:79-83.
40. Vallada HP, Gill M, Sham P, Lim LC, Nanko S, Asherson P, et al. (1995). Linkage studies on chromosome 22 in familial schizophrenia. Am J Med Genet 60:139-146.
41. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7:571-578.